tradingkey.logo
tradingkey.logo
검색

Genfit SA

GNFT
관심 목록에 추가
4.850USD
0.0000.00%
종가 07/02, 13:00ET시세는 15분 지연됩니다
741.27M시가총액
--P/E TTM

자세한 내용은 Genfit SA 회사

Genfit SA is a France-based biopharmaceutical company focused on the discovery and development of therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, particularly due to a lack of approved treatments. The Company provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The Company leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.

Genfit SA 정보

종목 코드 GNFT
회사 이름Genfit SA
상장일Dec 19, 2006
CEOPrigent (Pascal)
직원 수180
유형Depository Receipt
회계 연도 종료Dec 19
주소Parc Eurasante 885 avenue Eugene Avinee
도시LOOS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가France
우편 번호59120
전화33320164000
웹사이트https://www.genfit.fr/
종목 코드 GNFT
상장일Dec 19, 2006
CEOPrigent (Pascal)

Genfit SA의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Jean-Francois Mouney
Mr. Jean-Francois Mouney
Chairman of the Board of Directors
Chairman of the Board of Directors
--
--
Ms. Florence Sejourne
Ms. Florence Sejourne
Director, Representative of Biotech Avenir SAS
Director, Representative of Biotech Avenir SAS
--
--
Prof. Laurent Lannoo
Prof. Laurent Lannoo
Corporate Secretary, Director of Legal Affairs
Corporate Secretary, Director of Legal Affairs
--
--
Dr. Dean W. Hum, Ph.D.
Dr. Dean W. Hum, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Catherine Larue, Ph.D.
Dr. Catherine Larue, Ph.D.
Independent Director
Independent Director
--
--
Mr. Pascal Prigent
Mr. Pascal Prigent
Chief Executive Officer
Chief Executive Officer
--
--
Mrs. Anne-Helene Monsellato
Mrs. Anne-Helene Monsellato
Independent Director
Independent Director
--
--
Ms. Katherine Bach Kalin
Ms. Katherine Bach Kalin
Independent Director
Independent Director
--
--
Mr. Eric Baclet
Mr. Eric Baclet
Independent Vice-Chairman of the Board of Directors
Independent Vice-Chairman of the Board of Directors
--
--
Mr. Jean-Christophe Marcoux
Mr. Jean-Christophe Marcoux
Chief Corporate Affairs Officer, Head of Investor Relations, Head of ESG
Chief Corporate Affairs Officer, Head of Investor Relations, Head of ESG
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Jean-Francois Mouney
Mr. Jean-Francois Mouney
Chairman of the Board of Directors
Chairman of the Board of Directors
--
--
Ms. Florence Sejourne
Ms. Florence Sejourne
Director, Representative of Biotech Avenir SAS
Director, Representative of Biotech Avenir SAS
--
--
Prof. Laurent Lannoo
Prof. Laurent Lannoo
Corporate Secretary, Director of Legal Affairs
Corporate Secretary, Director of Legal Affairs
--
--
Dr. Dean W. Hum, Ph.D.
Dr. Dean W. Hum, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Catherine Larue, Ph.D.
Dr. Catherine Larue, Ph.D.
Independent Director
Independent Director
--
--
Mr. Pascal Prigent
Mr. Pascal Prigent
Chief Executive Officer
Chief Executive Officer
--
--

자주 묻는 질문

Genfit SA의 상위 5대 주주는 누구인가요?

Genfit SA의 상위 5대 주주는 다음과 같습니다: Mr. Jean-Francois Mouney

Genfit SA(GNFT)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Genfit SA의 주식을 보유한 기관은 총 16곳이며, 이들이 보유한 주식의 총 가치는 약 22.36K로 전체 발행 주식의 0.04%를 차지합니다. 이는 2025Q4 대비 -215235.00 증가한 수치입니다.